1. Home
  2. GEO vs TNGX Comparison

GEO vs TNGX Comparison

Compare GEO & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geo Group Inc (The) REIT

GEO

Geo Group Inc (The) REIT

HOLD

Current Price

$22.78

Market Cap

2.5B

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$19.66

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEO
TNGX
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
GEO
TNGX
Price
$22.78
$19.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$39.67
$21.78
AVG Volume (30 Days)
1.7M
2.6M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
727.27
26.89
EPS
0.29
N/A
Revenue
$2,263,420,000.00
$62,384,000.00
Revenue This Year
$13.74
N/A
Revenue Next Year
$9.99
N/A
P/E Ratio
$78.12
N/A
Revenue Growth
3.85
48.29
52 Week Low
$12.51
$1.93
52 Week High
$27.90
$28.41

Technical Indicators

Market Signals
Indicator
GEO
TNGX
Relative Strength Index (RSI) 62.59 39.92
Support Level $16.06 $7.08
Resistance Level N/A $22.01
Average True Range (ATR) 0.86 1.71
MACD -0.02 -0.49
Stochastic Oscillator 66.77 4.88

Price Performance

Historical Comparison
GEO
TNGX

About GEO Geo Group Inc (The) REIT

The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services. The company operates in U.S, Australia and South Africa.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: